Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted Gene Editing of Glia Maturation Factor in Microglia: a Novel Alzheimer’s Disease Therapeutic Target
Sudhanshu P. Raikwar, Ramasamy Thangavel, Iuliia Dubova, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 1, pp. 378-393
Open Access | Times Cited: 58

Showing 26-50 of 58 citing articles:

Virus-Based Biological Systems as Next-Generation Carriers for the Therapy of Central Nervous System Diseases
Ilona Nowak, Marcel Madej, Julia Secemska, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1931-1931
Open Access | Times Cited: 8
CRISPR/Cas9 Editing of Glia Maturation Factor Regulates Mitochondrial Dynamics by Attenuation of the NRF2/HO-1 Dependent Ferritin Activation in Glial Cells
Govindhasamy Pushpavathi Selvakumar, Mohammad Ejaz Ahmed, Sudhanshu P. Raikwar, et al.
Journal of Neuroimmune Pharmacology (2019) Vol. 14, Iss. 4, pp. 537-550
Open Access | Times Cited: 25
Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer’s Disease: Are We There Yet?
Sudhanshu P. Raikwar, Ramasamy Thangavel, Iuliia Dubova, et al.
Journal of Alzheimer s Disease (2018) Vol. 65, Iss. 2, pp. 321-344
Open Access | Times Cited: 24
New approaches to moderate CRISPR-Cas9 activity: Addressing issues of cellular uptake and endosomal escape
Maja van Hees, Sofie Slott, Anders Højgaard Hansen, et al.
Molecular Therapy (2021) Vol. 30, Iss. 1, pp. 32-46
Open Access | Times Cited: 19
The taste of neuroinflammation: Molecular mechanisms linking taste sensing to neuroinflammatory responses
Menizibeya O. Welcome, Nikos E. Mastorakis
Pharmacological Research (2021) Vol. 167, pp. 105557-105557
Closed Access | Times Cited: 18
Regenerative medicine improve neurodegenerative diseases
Seyedeh Sara Ashraf, Vahid Hosseinpour Sarmadi, Ghazaleh Larijani, et al.
Cell and Tissue Banking (2022) Vol. 24, Iss. 3, pp. 639-650
Open Access | Times Cited: 13
Extracellular vesicle and CRISPR gene therapy: Current applications in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease
Enes Akyüz, Feyza Şule Aslan, Enise Gokce, et al.
European Journal of Neuroscience (2024) Vol. 60, Iss. 8, pp. 6057-6090
Open Access | Times Cited: 2
CRISPR, Prime Editing, Optogenetics, and DREADDs: New Therapeutic Approaches Provided by Emerging Technologies in the Treatment of Spinal Cord Injury
Vera Paschon, Felipe Fernandes Correia, Beatriz Cintra Morena, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 4, pp. 2085-2100
Closed Access | Times Cited: 20
Battling Neurodegenerative Diseases with Adeno-Associated Virus-Based Approaches
Olja Mijanović, Ana Branković, Anton V. Borovjagin, et al.
Viruses (2020) Vol. 12, Iss. 4, pp. 460-460
Open Access | Times Cited: 19
Tripterygium glycoside ameliorates neuroinflammation in a mouse model of Aβ25-35-induced Alzheimer’s disease by inhibiting the phosphorylation of IκBα and p38
Liang Tang, Xiang Qin, Ju Xiang, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 8540-8554
Open Access | Times Cited: 17
A unified model of dementias and age‐related neurodegeneration
Michael Fossel
Alzheimer s & Dementia (2020) Vol. 16, Iss. 2, pp. 365-383
Open Access | Times Cited: 15
Real-Time Noninvasive Bioluminescence, Ultrasound and Photoacoustic Imaging in NFκB-RE-Luc Transgenic Mice Reveal Glia Maturation Factor-Mediated Immediate and Sustained Spatio-Temporal Activation of NFκB Signaling Post-Traumatic Brain Injury in a Gender-Specific Manner
Sudhanshu P. Raikwar, Ramasamy Thangavel, Mohammad Ejaz Ahmed, et al.
Cellular and Molecular Neurobiology (2020) Vol. 41, Iss. 8, pp. 1687-1706
Open Access | Times Cited: 13
Cellulose ether treatment inhibits amyloid beta aggregation, neuroinflammation and cognitive deficits in transgenic mouse model of Alzheimer’s disease
Tahir Ali, Antonia Klein, Keegan McDonald, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 4
CRISPR/Cas9 gene editing: A new hope for Alzheimer's disease
Gadde Shareena, Viswapriya Viswalingam, Mithun Singh Rajput, et al.
Elsevier eBooks (2024), pp. 301-323
Closed Access | Times Cited: 1
Application of CRISPR-Cas systems in neuroscience
Deepro Bonnerjee, Sangram Bagh
Progress in molecular biology and translational science (2021), pp. 231-264
Closed Access | Times Cited: 9
The efficient generation of knockout microglia cells using a dual-sgRNA strategy by CRISPR/Cas9
Mengfei Zhang, Yi Fang, Junjiao Wu, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 6
Advances in Optogenetics Applications for Central Nervous System Injuries
Yuanming Geng, Zhenxing Li, Junhao Zhu, et al.
Journal of Neurotrauma (2022) Vol. 40, Iss. 13-14, pp. 1297-1316
Open Access | Times Cited: 6
Glia Maturation Factor in the Pathogenesis of Alzheimer's disease.
Swathi Beladakere Ramaswamy, Sachin Bhagavan, Harleen Kaur, et al.
PubMed (2019) Vol. 12, Iss. 3, pp. 79-82
Closed Access | Times Cited: 7
Targeted Delivery for Neurodegenerative Disorders Using Gene Therapy Vectors: Gene Next Therapeutic Goals
Manisha Singh, Surinder P. Singh, Deepshikha Yadav, et al.
Current Gene Therapy (2020) Vol. 21, Iss. 1, pp. 23-42
Closed Access | Times Cited: 7
Glia Maturation Factor in the Pathogenesis of Alzheimer’s Disease
Duraisamy Kempuraj
Open access Journal of Neurology & Neurosurgery (2019) Vol. 12, Iss. 3
Open Access | Times Cited: 7
Recent advances in the use of CRISPR/Cas for understanding the early development of molecular gaps in glial cells
Carla P. Barragán-Álvarez, José Miguel Flores-Fernández, Oscar R. Hernández‐Pérez, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 3
Gene Editing Tool for Neurodegenerative Diseases
Mohd Yasir Khan, H.A. Khan, Farah Maarfi, et al.
(2024), pp. 359-390
Closed Access
CdSe Quantum Dot-Based Delivery System for CRISPR-Cas9 Mediated Microglial Gene Modulation
Hyeon-Gu Yeo, Jinyoung Won, Lee Wha Gwon, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 20, pp. 24013-24027
Open Access
CRISPR/Cas9-based genetic engineering for translational research in neurological disorders
Platon Megagiannis, Guy A. Rouleau, Yang Zhou
Elsevier eBooks (2024), pp. 187-206
Closed Access
CRISPR-Cas9 Gene Editing: A Promising Frontier in Revolutionizing Alzheimer’s Disease Management
Yuxin Jin
MedScien (2024) Vol. 1, Iss. 7
Open Access

Scroll to top